Zeynep Burcin Yilmaz

Dr. Zeynep Burcin Yilmaz

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MDMefküre Durmuş
Mefküre Durmuş
SKsena güzel karahan
sena güzel karahan
Sami AkbulutSami Akbulut
Sami Akbulut
ZYZeynep Burcin Yilmaz
Zeynep Burcin Yilmaz
EKErtugrul Karabulut
Ertugrul Karabulut
Background: Liver transplant recipients are highly susceptible to invasive fungal infections, particularly candidemia, due to intensive immunosuppressive therapy and postoperative complications. However, few studies have comprehensively examined postoperative antimicrobial and immunosuppressive factors in this context. Aim: This study aimed to identify perioperative and postoperative factors associated with the development of candidemia in living donor liver transplant (LDLT) recipients, with a particular focus on antimicrobial and immunosuppressive regimens during initial hospitalization. Methods: A retrospective case–control analysis was conducted involving 36 LDLT recipients who developed candidemia (candidemia group) and 72 matched controls without candidemia (non-candidemia group) between January 2019 and November 2023. Demographic and clinical variables were compared using univariate and multivariate logistic regression analyses to identify independent associations. A post hoc power analysis demonstrated a high statistical power (97.3%) to detect large effect sizes. Results: Univariate analysis revealed significant associations with prolonged intubation (p < 0.001), bile leaks (p < 0.001), relaparotomy (p < 0.001), chronic renal disease (p = 0.011), hepatocellular carcinoma (p = 0.011), and the use of antimicrobials including meropenem (p = 0.048), linezolid (p = 0.005), tigecycline (p = 0.045), third-generation cephalosporins (p = 0.003), anidulafungin (p < 0.001), fluconazole (p = 0.006), mycophenolate (p = 0.011), and total parenteral nutrition (TPN) (p = 0.049). CMV prophylaxis (p < 0.001) and CMV-PCR positivity (p = 0.015) were also significantly associated with candidemia. Multivariate logistic regression analysis identified prolonged intubation (OR = 1.07; p = 0.019), bile leaks (OR = 10.9; p = 0.002), anidulafungin use (OR = 4.70; p = 0.032), fluconazole use (OR = 35.8; p = 0.005), and absence of CMV prophylaxis (OR = 11.7; p = 0.021) as independent factors associated with increased odds of candidemia. Conclusions: Prolonged intubation, bile leaks, antifungal exposure, and lack of CMV prophylaxis are independently associated with higher odds of candidemia after LDLT. Targeted prophylaxis, prudent antimicrobial stewardship, and timely biliary intervention may reduce fungal morbidity and mortality in post-transplant patients.

29 May 2026 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
YGYakup Gezer
Yakup Gezer
MTMuhammet Rıdvan Tayşi
Muhammet Rıdvan Tayşi
ATArzu Tarakçı
Arzu Tarakçı
SASevil Alkan
Sevil Alkan
SKSelçuk Kaya
Selçuk Kaya
EÖEthem Ömeroğlu
Ethem Ömeroğlu
The coexistence of metabolic dysfunction-associated steatotic liver disease (MASLD) and chronic hepatitis B (CHB) may influence liver fibrosis, but the rel

29 August 2024
Verified
Book
Open access
PDF file
FFFatma Fırat
Fatma Fırat
ÖEÖykü Erik
Öykü Erik
EBEmrah Bilen
Emrah Bilen
DKderya korkmaz
derya korkmaz
NDNeşe Demirtürk
Neşe Demirtürk
Murat AYMurat AY
Murat AY
Oral Mukoza Histolojisi Fatma FIRAT Oral Kavitenin Sık Görülen Benign Durumları Gülhan GUREL Öykü ERİK Periodontal ve Dental Hastalıklar Emrah BİLEN Oral Mukozanın Bakteriyel Enfeksiyonları Derya KORKMAZ Oral Kandidiyazis ve Diğer Fungal Hastalıklar Neşe DEMİRTURK Oral Mukozanın Viral Enfeksiyonları Zeynep Burcin YILMAZ Petek ŞARLAK KONYA Rekürren Aftöz Stomatit Işın Nur Sultan ONCU Oral Liken Planus Dilara GULER Otoimmun Büllöz Hastalıkların Oral Mukoza Tutulumu İrem Nur DURUSU TURKOĞLU Fiziksel ve Kimyasal Etkenlere Bağlı Oral Reaksiyonlar Fatih CELENK Çağlar GUNEBAKAN Keilit Etiyolojisi ve Keilitli Hastaya Yaklaşım Necip Enis KAYA Emine COLGECEN Oral Mukozanın Premalign ve Malign Lezyonları Abdulkadir BUCAK Selçuk KUZU Oral Melanozis ve Melanom Bahar SUNCAK Çağrı TURAN Hematolojik ve Onkolojik Hastalıkların Oral Belirtileri Beyza UNLU Sistemik Hastalıkların Oral Bulguları Murat AY

25 June 2024 in Flora the Journal of Infectious Diseases and Clinical Microbiology
Verified
Journal Article
Closed access
ZYZeynep Burcin Yilmaz
Zeynep Burcin Yilmaz
YDYücel Duman
Yücel Duman
STSİBEL ALTUNIŞIK TOPLU
SİBEL ALTUNIŞIK TOPLU
FMFunda Memi̇şOğlu
Funda Memi̇şOğlu
Adem KoseAdem Kose
Adem Kose
YEYasemin Ersoy
Yasemin Ersoy

14 September 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
ZYZeynep Burcin Yilmaz
Zeynep Burcin Yilmaz
ZKZeynep Kucukakcali
Zeynep Kucukakcali
Sami AkbulutSami Akbulut
Sami Akbulut
Background: Dengue fever remains a major global health problem, and early diagnosis is challenging where confirmatory testing is limited. Machine-learning studies using routine hematological data have focused mainly on discrimination, whereas calibration, decision-analytic performance, interpretability, and robust validation have received less attention. This study aimed to develop and compare tree-based machine-learning models for dengue classification, benchmark them against L2-penalized logistic regression (LR), and evaluate discrimination, calibration, potential decision-analytic benefit, and interpretability. Methods: This retrospective secondary analysis used an open-access dataset from Bangladesh comprising 1523 patients, 18 demographic and hematological predictors, and a binary dengue test outcome. Data were divided into stratified training (80%) and test (20%) sets. The Synthetic Minority Over-sampling Technique was applied only within the training workflow. Random Forest (RF), XGBoost, and LightGBM were optimized using Optuna with stratified five-fold cross-validation. L2-penalized LR was evaluated using the same predictors and training–test partition. Held-out test-set performance was assessed using AUROC, AUPRC, accuracy, sensitivity, specificity, predictive values, F1-score, and Brier score. Calibration, decision curve analysis, SHAP values, and permutation importance were also examined. Results: LightGBM, RF, and XGBoost yielded AUROCs of 0.709, 0.704, and 0.702, respectively, indicating closely similar discrimination. The primary SMOTE-trained LR yielded a numerically lower AUROC of 0.608 (95% CI: 0.536–0.677) and a higher Brier score of 0.310 than the tree-based models (0.174–0.176); however, in sensitivity analysis without SMOTE, the LR AUROC increased numerically to 0.655 and the Brier score decreased to 0.194. At the training-derived threshold of 0.558, LightGBM achieved a sensitivity of 0.914 and a specificity of 0.458, reflecting a high-sensitivity, low-specificity profile. The LightGBM calibration curve suggested closer agreement in the low-to-moderate predicted-probability range, with greater deviation at higher probabilities. Decision curve analysis suggested potential net benefit across a range of threshold probabilities but did not establish clinical utility. Platelet count, monocyte percentage, and neutrophil percentage were consistently among the leading predictors across the tree-based models. Conclusions: Tree-based models showed moderate discrimination, with high sensitivity but limited specificity, and yielded numerically higher AUROCs and lower Brier scores than the primary SMOTE-trained LR within this internal-validation framework. They should not replace etiological testing or be used as standalone diagnostic tools; their observed operating characteristics are more compatible with a potential adjunctive screening or triage-support role. External and prospective validation across independent populations and settings is required before clinical use or superiority over simpler statistical models can be established.

13 September 2026 in Viruses
Verified
Journal Article
Open access
PDF file
ZYZeynep Burcin Yilmaz
Zeynep Burcin Yilmaz
ZKZeynep Kucukakcali
Zeynep Kucukakcali
Sami AkbulutSami Akbulut
Sami Akbulut
Background: Whole-blood transcriptomic profiling can capture systemic immune-response alterations associated with COVID-19 and may support host-response-based classification. However, evidence regarding the discriminatory value of targeted immune-gene panels remains limited, and in small, high-dimensional datasets, the timing of feature selection may substantially affect model performance and interpretation. Aim: This study aimed to evaluate whether NanoString Human Immunology Panel profiles could distinguish COVID-19 from healthy-control measurements and to compare full-dataset feature selection (FDFS) with leave-one-out cross-validation (LOOCV)-embedded feature selection (LEFS). Methods: Publicly available E-MTAB-8871 data comprising 579 genes and 32 whole-blood transcriptomic profiles were analyzed. The dataset included 22 longitudinal COVID-19 measurements obtained from three participants and 10 measurements obtained from 10 healthy controls. Elastic Net regularization was used for feature selection. Random Forest, XGBoost, and LightGBM classifiers were evaluated using sample-level LOOCV. Model performance was assessed using threshold-dependent, discrimination, and probability-based metrics. A separate exploratory LightGBM model was analyzed using SHapley Additive exPlanations (SHAP) to characterize feature contributions. Results: FDFS identified a fixed 40-gene set, whereas LEFS selected a mean of 42 genes per fold (range: 40–47). LightGBM correctly classified all 32 measurement-level profiles (derived from 13 unique participants: 10 healthy controls and three longitudinally sampled COVID-19 participants) in both frameworks, achieving area under the receiver operating characteristic curve (ROC-AUC) and area under the precision–recall curve (PR-AUC) values of 1.000 and Brier scores of 0.005 and 0.006 in the FDFS and LEFS frameworks, respectively. Random Forest achieved accuracies of 0.969 and 1.000, whereas XGBoost achieved an accuracy of 0.969 in both frameworks. SHAP analyses consistently identified AICDA as the dominant contributor to model predictions, followed by ARHGDIB. Conclusions: This exploratory analysis showed that targeted NanoString immune-response profiles contained a compact transcriptomic signal capable of distinguishing COVID-19 from healthy-control measurements within the analyzed dataset. These findings provide proof-of-concept evidence of internal measurement-level discrimination. However, because the COVID-19 profiles consisted of repeated measurements from only three participants, sample-level LOOCV did not constitute independent participant-level validation. External validation in larger cohorts comprising independently sampled participants is required. Given that the COVID-19 arm comprised only three independent participants, these biological findings should be regarded as hypothesis-generating and require validation in substantially larger independent cohorts.